» Articles » PMID: 20736202

The NCDR ACTION Registry-GWTG: Transforming Contemporary Acute Myocardial Infarction Clinical Care

Overview
Journal Heart
Date 2010 Aug 26
PMID 20736202
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: The NCDR ACTION Registry-GWTG collects detailed in-hospital clinical, process-of-care and outcomes data for patients admitted with acute myocardial infarction (AMI) in the USA. The registry is a national AMI surveillance system that contributes to the scientific enquiry process of AMI care through the facilitation of local and national quality improvement efforts.

Interventions: No treatments are mandated, participating centres receive routine quality-of-care and outcomes performance feedback reports and access to quality of care tools, such as dosing algorithms and standing orders.

Population: AMI patients are retrospectively identified. No informed consent is required, as data are anonymised. From January 2007 to date, 147 165 records have been submitted from 383 participating US hospitals. Patients with a primary diagnosis of ST-segment elevation myocardial infarction or non-ST-segment elevation myocardial infarction are eligible for enrolment in the registry. These patients must have ischemic symptoms and electrocardiogram changes, and/or positive cardiac markers within 24 hours of initial presentation.

Baseline Data: Approximately 350 fields encompassing patient demographics, medical history and risk factors, hospital presentation, initial cardiac status, medications and associated doses, reperfusion strategy, procedures, laboratory values, and outcomes. Data are manually entered by study personnel; there are non-financial incentives at the hospital level. Completeness within the registry is noteworthy with most fields at less than 5% missing.

Endpoints: Main outcome measures include American College of Cardiology/American Heart Association myocardial infarction performance indicators, as well as in-hospital patient outcomes. Data are available for research by application to: http://www.ncdr.com.

Citing Articles

Optimizing Prediction of In-Hospital Mortality in Elderly Patients With Acute Myocardial Infarction: A Nomogram Approach Using the Age-Adjusted Charlson Comorbidity Index Score.

Lin H, Xi Y, Yang Z, Tong Z, Jiang G, Gao J J Am Heart Assoc. 2024; 13(14):e032589.

PMID: 38979832 PMC: 11292757. DOI: 10.1161/JAHA.123.032589.


Influence of time-to-diagnosis on time-to-percutaneous coronary intervention for emergency department ST-elevation myocardial infarction patients: Time-to-electrocardiogram matters.

Yiadom M, Gong W, Patterson B, Baugh C, Mills A, Gavin N J Am Coll Emerg Physicians Open. 2024; 5(3):e13174.

PMID: 38726468 PMC: 11079543. DOI: 10.1002/emp2.13174.


Real-World Evidence on Disparities on the Initiation of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome.

Yildirim M, Mueller-Hennessen M, Milles B, Biener M, Hund H, Frey N J Am Heart Assoc. 2023; 12(16):e030879.

PMID: 37581388 PMC: 10492934. DOI: 10.1161/JAHA.123.030879.


Prognostic Significance of Activated Monocytes in Patients with ST-Elevation Myocardial Infarction.

Abo-Aly M, Shokri E, Chelvarajan L, Tarhuni W, Tripathi H, Abdel-Latif A Int J Mol Sci. 2023; 24(14).

PMID: 37511100 PMC: 10378894. DOI: 10.3390/ijms241411342.


Rationale and Study Design of the TSOC-Fully Organized Registry for the Management of Symptomatic ACS Study (T-FORMOSA Study).

Chao T, Yeh H, Shyu K, Lai C, Lee J, Huang C Acta Cardiol Sin. 2023; 39(4):561-571.

PMID: 37456948 PMC: 10346056. DOI: 10.6515/ACS.202307_39(4).20230306D.